Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Biogen/Sage’s Zuranolone Data May Not Be Enough For Tough Commercial Landscape
Phase III Data Seen As Underwhelming
Jun 15 2021
•
By
Alaric DeArment
Biogen/Sage announce results of WATERFALL study of zuranolone in major depressive disorder • Source: Shutterstock
More from Business
More from Scrip